157 related articles for article (PubMed ID: 34272932)
1. Prognostic significance of high circulating sHLA-G in ovarian carcinoma.
Babay W; Boujelbene N; Ben Yahia H; Bortolotti D; Zemni I; Ouzari HI; Chelbi H; Mezlini A; Rizzo R; Zidi I
HLA; 2021 Oct; 98(4):357-365. PubMed ID: 34272932
[TBL] [Abstract][Full Text] [Related]
2. Increased plasmatic soluble HLA-G levels in endometrial cancer.
Ben Yahia H; Babay W; Bortolotti D; Boujelbene N; Laaribi AB; Zidi N; Kehila M; Chelbi H; Boudabous A; Mrad K; Mezlini A; Di Luca D; Ouzari HI; Rizzo R; Zidi I
Mol Immunol; 2018 Jul; 99():82-86. PubMed ID: 29730546
[TBL] [Abstract][Full Text] [Related]
3. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
[TBL] [Abstract][Full Text] [Related]
4. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.
Rebmann V; Lemaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
Hum Immunol; 2005 Aug; 66(8):853-63. PubMed ID: 16216668
[TBL] [Abstract][Full Text] [Related]
5. Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage.
Fainardi E; Rizzo R; Lupato A; Ramponi V; De Santis G; Garofano F; Stignani M; Tamborino C; Castellazzi M; Casetta I; Baricordi OR
Acta Neurochir Suppl; 2010; 106():141-5. PubMed ID: 19812937
[TBL] [Abstract][Full Text] [Related]
6. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
[TBL] [Abstract][Full Text] [Related]
7. sHLA-G1 and HLA-G5 levels are decreased in Tunisian women with multiple abortion.
Zidi I; Rizzo R; Bouaziz A; Laaribi AB; Zidi N; Di Luca D; Tlili H; Bortolotti D
Hum Immunol; 2016 Apr; 77(4):342-5. PubMed ID: 26812178
[TBL] [Abstract][Full Text] [Related]
8. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis.
Zheng J; Xu C; Chu D; Zhang X; Li J; Ji G; Hong L; Feng Q; Li X; Wu G; Du J; Zhao Q
Immunol Lett; 2014 Sep; 161(1):13-9. PubMed ID: 24768599
[TBL] [Abstract][Full Text] [Related]
9. Quantification and identification of soluble HLA-G isoforms.
Rebmann V; LeMaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
Tissue Antigens; 2007 Apr; 69 Suppl 1():143-9. PubMed ID: 17445190
[TBL] [Abstract][Full Text] [Related]
10. Detection of serum soluble HLA-G levels in patients with acute ischemic stroke: A pilot study.
Fainardi E; Bortolotti D; Castellazzi M; Casetta I; Bellini T; Rizzo R
Hum Immunol; 2020 Apr; 81(4):156-161. PubMed ID: 31735441
[TBL] [Abstract][Full Text] [Related]
11. Significance of tumour cell HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients.
Yan WH; Liu D; Lu HY; Li YY; Zhang X; Lin A
J Cell Mol Med; 2015 Apr; 19(4):778-85. PubMed ID: 25689063
[TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.
König L; Kasimir-Bauer S; Hoffmann O; Bittner AK; Wagner B; Manvailer LF; Schramm S; Bankfalvi A; Giebel B; Kimmig R; Horn PA; Rebmann V
Hum Immunol; 2016 Sep; 77(9):791-9. PubMed ID: 26796737
[TBL] [Abstract][Full Text] [Related]
13. Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Caniatti ML; Baldi E; Tola MR; Granieri E; Baricordi OR
J Neuroimmunol; 2007 Dec; 192(1-2):219-25. PubMed ID: 17997167
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
[TBL] [Abstract][Full Text] [Related]
15. Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.
Kirana C; Ruszkiewicz A; Stubbs RS; Hardingham JE; Hewett PJ; Maddern GJ; Hauben E
Int J Cancer; 2017 Jun; 140(11):2577-2586. PubMed ID: 28233298
[TBL] [Abstract][Full Text] [Related]
16. HLA-G is a potential tumor marker in malignant ascites.
Singer G; Rebmann V; Chen YC; Liu HT; Ali SZ; Reinsberg J; McMaster MT; Pfeiffer K; Chan DW; Wardelmann E; Grosse-Wilde H; Cheng CC; Kurman RJ; Shih IeM
Clin Cancer Res; 2003 Oct; 9(12):4460-4. PubMed ID: 14555519
[TBL] [Abstract][Full Text] [Related]
17. Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.
Ugurel S; Rebmann V; Ferrone S; Tilgen W; Grosse-Wilde H; Reinhold U
Cancer; 2001 Jul; 92(2):369-76. PubMed ID: 11466692
[TBL] [Abstract][Full Text] [Related]
18. Impact of blood processing on estimation of soluble HLA-G.
Poláková K; Bandžuchová E; Russ G
Neoplasma; 2011; 58(4):337-42. PubMed ID: 21520991
[TBL] [Abstract][Full Text] [Related]
19. Association of soluble HLA-G plasma levels with HLA-G alleles.
Rebmann V; van der Ven K; Pässler M; Pfeiffer K; Krebs D; Grosse-Wilde H
Tissue Antigens; 2001 Jan; 57(1):15-21. PubMed ID: 11169254
[TBL] [Abstract][Full Text] [Related]
20. HLA-G expression is an independent predictor for improved survival in high grade ovarian carcinomas.
Rutten MJ; Dijk F; Savci-Heijink CD; Buist MR; Kenter GG; van de Vijver MJ; Jordanova ES
J Immunol Res; 2014; 2014():274584. PubMed ID: 24987709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]